Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients - Alping, Peter; Askling, Johan; Burman, Joachim; Fink, Katharina; Fogdell‐Hahn, Anna; Gunnarsson, Martin; Hillert, Jan; Langer‐Gould, Annette; Lycke, Jan; Nilsson, Petra; Salzer, Jonatan; Svenningsson, Anders; et al. (Annals of neurology, 2020)
Keywords: Cancer; Cancer and Oncology; Cancer och onkologi; Clinical Medicine; Comparative studies; Confidence intervals; Health risks; Immunotherapy; Invasiveness; Klinisk medicin; Medical and Health Sciences; Medicin och hälsovetenskap; Monoclonal antibodies; Multiple sclerosis; Neurologi; Neurology; Neurosciences; Neurovetenskaper; Population; Risk; Rituximab; Targeted cancer therapy